Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 7-8, 2008, Pages 420-425

  Rybus Kalinowska, Barbara ^a,d,e   Zwirska Korczala, Krystyna ^a   Kalinowski, Mariusz ^b   Kukla, Michat ^a   Birkner, Ewa ^c   Jochem, Jerzy ^d  

^a Institute of Physiology   (Poland)

^b Clinical Department of Cardiology of SCCS   (Poland)

^c Institute of Biochemistry   (Poland)

^d Department of Anatomy and Embryology   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Graves Basedow disease; Oxidative status

Indexed keywords

COPPER; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MANGANESE; SUPEROXIDE DISMUTASE; THIAMAZOLE; ZINC;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ERYTHROCYTE; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; OXIDATIVE STRESS;

EID: 49249083686     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.438     Document Type: Article

References (36)

1. Mano T, Shinohra R, Sawai Y, et al. Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle. J Endocrinol. 1995; 145: 13-16.
2. Carrion Y, Fernandez V, Videla LA. Influence of thyroid hormone administration on hepatic glutathione content and basolateral gamma-glutamyltransferase ectoactivity in the isolated perfused rat liver. Biochem Pharmacol. 1993; 45: 2527-2535.
3. Fernandez V, Simizu K, Barras SB, et al. Effects of hyperthyroidism on rat liver glutathione metabolism: related enzyme activities, effux, and turnover. Endocrinology. 1991; 129: 85-91.
4. Niki E, Noguchi N, Tsuchihashi H, et al. Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr. 1995; 62 (6 Suppl): S1322-S1326.
5. Fridovich I. The biology of oxygen radicals. Science. 1978; 201: 875-880.
6. Kang DH. Oxidative stress, DNA damage and breast cancer. AACN Clin Issues 2002; 13: 540-549.
7. Skrzycki M, Czeczot H. Extracellular superoxide dismutase (EC-SOD) - structure, properties and functions. Postepy Hig Med Dośw. 2004; 24: 301-311.
8. Sugawara M, Kita T, Lee ED, et al. Deficiency of superoxide in endemic goiter tissue. J Clin Endocrinol Metab. 1988; 67: 1156-1161.
9. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588-590.
10. Inal ME, Kanbak G, Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta. 2001; 305: 75-80.
11. Bartosz G. Druga twarz tlenu. Wolne rodniki w przyrodzie. Warszawa, Wydawnictwo Naukowe PWN, 2003.
12. Ahsan H, Ali A, Ali R. Oxygen free radicals and systematic autoimmunity. Clin Exp Immunol. 2003; 131: 398-404.
13. Weetman AP, Holt ME, Campbell AK, et al. Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppresion. Br Med J (Clin Res Ed). 1984; 288: 518-520.
14. Burch HB, Barnes S, Nagy EV, et al. Immunodetection of manganese superoxide dismutase in cultured human retroocular fibroblast using sera directed against the thyrotropin receptor. J Endocrinol Invest. 1998; 21: 48-55.
15. Burch HB, Lahiri S, Bahn RS, et al. Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophtalmopathy. Exp Eye Res. 1997; 65: 311-316.
16. Oyanagui Y. Reevaluation of assay methods and establishment of kid for superoxide dismutase activity. Anal Biochem. 1984; 142: 290-296.
17. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutatione peroxidase. J Lab Clin Med. 1967; 70: 158-169.
18. Ohkawa H, Ohishi N, Yagi K. Assay for peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-358.
19. Andryskowski G, Owczarek T. Ocena wybranych parametrów stresu oksydacyjego u chorych z nadczynnościa̧ tarczycy. Pol Arch Med Wewn. 2007; 117: 285-289.
20. Komosińska-Vassev K, Olczyk K, Kucharz EJ, et al. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta. 2000; 300: 107-117.
21. Cetinkaya A, Kurutas EB, Buyukbese MA, et al. Levels of malondialdehyde and superoxide dismutase in subclinical hyperthyroidism. Mediators Inflamm. 2005; 24: 57-59.
22. Mayer L, Romic Z, Skreb F, et al. Antioxidant in patients with hyperthyroidism. Clin Chem Lab Med. 2004; 42: 154-158.
23. Fernandez V, Tapia G, Varela P, et al. Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of kappaB-alfa phosphorylation and nuclear factor-kappaB activation. J Endocrinol. 2005; 186: 539-547.
24. Mano T, Sinohara R, Sawai Y, et al. Changes in lipid peroxidation and free radical scavengers in the brain of hyper- and hypothyroid age rats. J Endocrinol. 1995; 147: 361-365.
25. 2 scavenging. Mol Pharmacol. 2001; 60: 972-980.
26. Seven A, Seymen O, Hatemi S, et al. Lipid peroxidation and vitamin E suplementation in experimental hyperthyroidism. Clin Chem. 1996; 42: 1118-1119.
27. Augustyniak K, Skrzydlewska E. Antioxidative abilities during aging. Postepy Hig Med Dośw. 2004; 58: 194-200.
28. Bednarek J, Wysocki H, Sowiński J. The effect of one-month antithyroid on peripheral metabolism of reactive oxygen in Graves' disease with infiltrative ophthalmopathy. Przegl Lek. 2004; 61: 841-844.
29. Abalovich M, Llesuy S, Gutierrez S, et al. Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments. Clin Endocrinol. 2003; 59: 321-327.
30. Grubeck-Loebenstein B, Buchan G, Chantry D, et al. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alfa and interleukin-6. Clin Exp Immunol. 1989: 77; 324-330.
31. Margolick JB, Weetman AP, Burman KD. Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma. Clin Immunol Immunopathol. 1988; 47: 208-218.
32. Adali M, Inal-Erden M, Akalin A, et al. Effects of propylthiouracyt, propranolol and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients. Clin Biochem. 1999; 32: 363-367.
33. Bianchi G, Solari E, Zaccheroni V, et al. Oxidative stress and anti-oxidant metabolites patients with hyperthyroidism: effect of treatment. Horm Metab Res. 1999; 31: 620-624.
34. Ademoglu E, Gookkusu C, Yarman S, et al. The effect of methimazole on the oxidant system in patients with hyperthyrpoidism. Pharmacol Res. 1998; 38: 93-96.
35. Assayama K, Dobashi K, Hayashibe H, et al. Vitamin E protects against thyroxine-induced acceleration of lipid peroxidation in cardiac and sceletal muscles in rats. J Nutr Sci Vitaminol. 1989; 35: 407-418.
36. Guerra LN, Rios de Molina Mdel C, et al. Antioxidant and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels. Clin Chim Acta. 2005; 352: 115-120.